Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

EuclidSR Partners

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 19
Average round size
info
The average size of a deal this fund participated in
$24M
Portfolio companies 11
Rounds per year 0.37
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.42
Exits 8
Key employees 2
Stages of investment
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Manufacturing
  • Life Science
Summary

EuclidSR Partners is the famous VC, which was founded in 1970. The venture was found in North America in United States. The leading representative office of defined VC is situated in the New York.

Among the most popular portfolio startups of the fund, we may highlight Xan3D Technologies, iJET International, iJET International. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has exact preference in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Manufacturing, Medical.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the EuclidSR Partners, startups are often financed by Versant Ventures, InterWest Partners, Novitas Capital. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, Novitas Capital, InterWest Partners. In the next rounds fund is usually obtained by Warburg Pincus, Versant Ventures, InterWest Partners.

Comparing to the other companies, this EuclidSR Partners performs on 11 percentage points more the average number of lead investments. The higher amount of exits for fund were in 2011. The usual things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2001. Speaking about the real fund results, this VC is 7 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year.

The overall number of key employees were 2.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of EuclidSR Partners:
Typical Co-investors
EuclidSR Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after EuclidSR Partners:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Blue Vista Ventures Alpharetta, Georgia, United States
F&Y Capital China, Guangdong, Shenzhen
Minneapolis Heart Institute Ventures -
NPM Capital Amsterdam, Noord-Holland, The Netherlands
Songshan Capital China, Hebei, Xicheng
SoupMaster China, Shanghai
Streamlined Ventures California, San Francisco, United States
Toyo Seikan Group Holdings Japan, Tokyo
United Investors business angels -
VWX Capital -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Melinta

Biotechnology
Emergency Medicine
Health Care
Pharmaceutical
$50M20 Jun 2006 New Haven, Connecticut, United States

Xan3D Technologies

3D Technology
Information Technology
Manufacturing
Semiconductor
$15M20 May 2004 New Hampshire, United States

iJET International

Business Intelligence
Risk Management
Travel
$5M16 Mar 2004 Annapolis, Maryland, United States

KuDOS Pharmaceuticals Ltd

Biotechnology
Health Care
Pharmaceutical
$54M01 Sep 2002 England

Xan3D Technologies

3D Technology
Information Technology
Manufacturing
Semiconductor
$40M28 Jan 2002 New Hampshire, United States

Melinta

Biotechnology
Emergency Medicine
Health Care
Pharmaceutical
$22M02 Jan 2002 New Haven, Connecticut, United States

Fluidigm

Biotechnology
Genetics
Life Science
Manufacturing
$34M12 Nov 2001 South San Francisco, California, United States

iJET International

Business Intelligence
Risk Management
Travel
$8M22 Jun 2001 Annapolis, Maryland, United States

Acurian

Clinical Trials
Health Care
Medical
Pharmaceutical
$27M28 Mar 2001 Horsham Township, Pennsylvania, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent EuclidSR Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 19
Average round size 24M
Rounds per year 0.37
Peak activity year 2002
Lead investments 3
Follow on index 0.42
Exits 8
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Melinta

Biotechnology
Emergency Medicine
Health Care
Pharmaceutical
$50M20 Jun 2006 New Haven, Connecticut, United States

Xan3D Technologies

3D Technology
Information Technology
Manufacturing
Semiconductor
$15M20 May 2004 New Hampshire, United States

iJET International

Business Intelligence
Risk Management
Travel
$5M16 Mar 2004 Annapolis, Maryland, United States

KuDOS Pharmaceuticals Ltd

Biotechnology
Health Care
Pharmaceutical
$54M01 Sep 2002 England

Xan3D Technologies

3D Technology
Information Technology
Manufacturing
Semiconductor
$40M28 Jan 2002 New Hampshire, United States

Melinta

Biotechnology
Emergency Medicine
Health Care
Pharmaceutical
$22M02 Jan 2002 New Haven, Connecticut, United States

Fluidigm

Biotechnology
Genetics
Life Science
Manufacturing
$34M12 Nov 2001 South San Francisco, California, United States

iJET International

Business Intelligence
Risk Management
Travel
$8M22 Jun 2001 Annapolis, Maryland, United States

Acurian

Clinical Trials
Health Care
Medical
Pharmaceutical
$27M28 Mar 2001 Horsham Township, Pennsylvania, United States
Crunchbase icon

Content report

The following text will be sent to our editors: